Ubidecarenone: Indication, Dosage, Side Effect, Precaution

Concise Prescribing Info Full Prescribing Info

Dosage/Direction for Use Administration Special Precautions Adverse Reactions Drug Interactions Action CIMS Class ATC Classification

Concise Prescribing Info

Indications/Uses

Listed in Dosage.

Dosage/Direction for Use

Adult: PO Heart failure 50-150 mg/day in 2-3 divided doses. Angina pectrois 150-600 mg/day in divided doses.

Administration

Should be taken with food.

Special Precautions

Avoid intense exercise during ubidecarenone therapy.

Adverse Reactions

Gastric discomfort, anorexia, diarrhoea, nausea, skin rash, heart burn. Increase in LFT with doses >300 mg/day.

Drug Interactions

Decreased serum levels with statins. Possible decrease in INR with warfarin.

CIMS Class

Supplements & Adjuvant Therapy / Cardiac Drugs

ATC Classification

C01EB09 - ubidecarenone ; Belongs to the class of other cardiac preparations.

Disclaimer: This information is independently developed by CIMS based on ubidecarenone from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com